(via TheNewswire)
Highlights:
Complementary acquisition of digital wellness company withAUD$2.5M cash on hand
Digital Mind Technology has a fully funded Phase 1 Clinical Trial ongoing
Adds several new high profile and leading institutional psychedelic funds as Blackhawk shareholders
MindBio Therapeutics fully funded Phase 2 Clinical Trials
Blackhawk holding leading assets in legal psychedelic and mental health therapies
Blackhawk is also pleased to announce that MindBio Therapeutics is accelerating its clinical trial program and is now fully funded for Phase 2 Clinical Trial for microdosing ofpsychedelic in late-stage cancer patients. MindBio will be one of a handful of companies that is progressing to a Phase 2 clinical trial in the psychedelics sector.
Digital Mind Technologyis an arms-length privately held clinical trial stage company developing digital interventions to treat mental health conditions. It successfully completed a pilot randomized controlled trial with 69 patients of an online mindfulness-based program for people diagnosed with melanoma1. Digital Mind’s clinical trial protocol was developed by leading scientist,
Following this,
The focus of the program was to empower participants to manage their health by promoting awareness of emotions and teaching skills to manage distressing thoughts. Central to the success of the program was the flexibility offered to participants to access the information at their own convenience.
Digital Mind has both the intellectual property, with over 5 years of quality research intellectual property and the capital, with approximately AUD$2.5million in working capital to fund its operations. Digital Mind will conduct Phase 1 clinical trials of mindfulness-based digital programs for people requiring pain management to avoid or reduce the impact on mental health. The clinical trials will be fully compliant with the Food and Drug Administration’s (FDA) protocol.
Digital Mind is also working to develop digital platforms (Mobile, Smart Watch, and Web) that provides clinically proven mindfulness-based digital programs to help patients to deal with pain. These clinical programs have the potential to be provided to patients via health professionals in a clinical setting.
Digital intervention technologies are one of the fastest growth areas in the treatment and prevention of mental health conditions. Funding for technology companies that are developing applications to treat behavioural, mental and brain health exceeded
“The acquisition of Digital Mind will help scale our life science and psychedelic portfolio tremendously” said
Dr.
She holds a PhD in psychology and a Master of Business Administration and a Master of Education. She has a wealth of experience in health changes and strategic advocacy to governments.
Digital Mind also has several high-profile shareholders including some of the largest psychedelic funds who will now become shareholders of Blackhawk through this acquisition. They include for instance:
Iter Investments
Iter Investments is a venture capital firm based in the
https://www.iterinvestments.com/
https://theconscious.fund/
Transaction Structure
In connection with the acquisition, Blackhawk will acquire all of the outstanding share capital of
Blackhawk is at arm's length from Digital Mind and its shareholders. The transaction neither constitutes a fundamental change nor a change of business for Blackhawk, nor is it expected to result in a change of control of Blackhawk within the meaning of applicable securities laws and the policies of the Canadian Securities Exchange. Completion of the acquisition remains subject to the satisfaction of customary closing conditions. Following completion of the acquisition, Digital Mind will expand Blackhawk’s existing portfolio of investments in the health care sector.
About
Blackhawk is an investment holding company looking to create substantial value for its shareholders through the acquisition and development of high growth companies. It has focused its investments in the health, cannabis and cannabidiol industries in both
The Company diligently posts updates through videos from the official company YouTube channelhttps://www.youtube.com/channel/UCs4f2tt3yAvOGhNLjgNOy-A
Please join the conversation on our Blackhawk group supporter’s telegram group athttps://t.me/Blackhawkgrowthcorpand visit us online athttps://www.blackhawkgrowth.com.
For further information please contact:
(403)-991-7737
fred@blackhawkgrowth.com
Publications By
Russell, L., Whiffen, R., Chapman, L., Just, J., Dean, E., Ugalde, A. and White, S., 2021.Hospital staff perspectives on the provision of smoking cessation care: a qualitative description study. BMJ open, 11(5), p.e044489. DOI: 10.1136/bmjopen-2020-044489
Lynch, F.A.; Katona, L.; Jefford, M.;
Smith, A.B. ; Shaw, J.; Dhillon, H.M.; Ellen, S.; Phipps-Nelson, J.; Lai-Kwon, J.; Milne, D.; Russell, L.; Dax, V.; Diggens, J.; Kent, H.; Button-Sloan, A.; Elliott, J.;Shackleton , M.; Burridge, H.; Ftanou, M.Feasibility and Acceptability of Fear-Less: A Stepped-Care Program to Manage Fear of Cancer Recurrence in People with Metastatic Melanoma.J. Clin . Med. 2020, 9, 2969. DOI: 10.3390/jcm9092969Russell, L., McIntosh, R., Martin, C., Scott J.,
Kheng Soo W ., Zappa B., Haynes K., Livingston PM. Ugalde, A.A model of cancer survivorship care within a community health setting: the Good Life Cancer Survivorship program.Journal of Cancer Survivorship . 2019 DOI: 10.1007/s11764-019-00821-6Russell, L., Ugalde, A., White, V., Pitcher, M., Jorgensen, S., Whitfield, K., ... Livingston, P.Relevance of mindfulness practices for Culturally And Linguistically Diverse cancer populations. PsychoOncology, 2019 DOI: 10.1002/pon.5221
Ugalde A, Haynes K, White V, Russell L, Livingston PM.“An Ambition to Make People Feel at Home” or “The Emperor’s New Clothes”? Professional Stakeholder Views of Wellness Centres in Cancer Care.
European Journal of Cancer Care . 2019 DOI: 10.1111/ecc.13096Russell L, Pascoe MC, Seymour JF, Aranda S, Butow P, Gough K, Schofield P.The trials and tribulations of conducting an m-health pilot randomized controlled trial to improve oral cancer therapy adherence: recommendations for future multisite, non-drug clinical trials.BMC research notes. 2019 Dec;12(1):226.
Russell L, Ugalde A, Orellana L, Milne D, Krishnasamy M, Chambers C, Austin D and Livingston P M,A pilot randomised controlled trial of an online mindfulness-based program for people diagnosed with melanoma,
Journal of Supportive Care in Cancer. 2018 DOI: 10.1007/s00520-018-4574-6Russell L, Ugalde A, Milne D, Austin D and Livingston P M,Digital Characteristics and Dissemination Indicators to Optimize Delivery of Internet-Supported Mindfulness-Based Interventions for People With a Chronic Condition: Systematic Review,
JMIR Mental Health . 2018 DOI: 10.2196/mental.9645Russell L, Ugalde A, Milne D, Krishnasamy M, Chung Seul O E, Austin D, Chambers R, Orellana L, and Livingston PM,Feasibility of an online mindfulness-based program for patients with melanoma: study protocol for a randomised controlled trial, Trials. 2018 Dec; 19(1):223
Pereira-Salgado A, Westwood JA, Russell L, Ugalde A, Ortlepp B, Seymour JF, Butow P, Cavedon L, Ong K, Aranda S, Breen S.,… Schofield P,Mobile Health Intervention to Increase Oral Cancer Therapy Adherence in Patients With Chronic Myeloid Leukemia (The REMIND System): Clinical Feasibility and Acceptability Assessment, JMIR mHealth and uHealth. 2017. DOI: 10.2196/mhealth.8349
Russell L, Orellana L, Ugalde A, Milne D, Krishnasamy M, Chambers R, Livingston PM.,Exploring Knowledge, Attitudes, and Practice Associated With Meditation Among Patients With Melanoma, Integrative Cancer Therapies, 2017. DOI: 10.1177/1534735417699514
Jefford M, Gough K, Drosdowsky A, Russell L, Aranda S, Butow P,
Phipps-Nelson J , Young J, Krishnasamy M, Ugalde A, King D., … and Schofield P,A Randomized Controlled Trial of a Nurse-Led Supportive Care Package (SurvivorCare) forSurvivors of Colorectal Cancer , Oncologist, 2016. DOI: 10.1634/theoncologist.2015-0533Russell L, Gough K, Drosdowsky A, Schofield P, Aranda S, Butow PN, Westwood JA, Krishnasamy M, Young JM,
Phipps-Nelson J , KingD. Jefford M , ,Psychological distress, quality of life, symptoms and unmet needs of colorectal cancer survivors near the end of treatment,Journal of Cancer Survivorship , 2015. DOI: 10.1007/s11764-014-0422-yJefford M, Mann GB, Nolte L, Russell L, Brennan M.,Follow-up of Women with Early Stage Breast Cancer. Current Breast Cancer Reports, 2014. DOI:10.1007/s12609-014-0150-3
Jefford M, Aranda S, Gough K,
Lotfi-Jam K , Butow P, Krishnasamy M, Young J,Phipps-Nelson J , Russell L, King D, Schofield P.,Evaluating a nurse-led survivorship care package (SurvivorCare) for bowel cancer survivors: study protocol for a randomized controlled trial, Trials 2013. DOI: 10.1186/1745-6215-14-260
Cautionary Note Regarding Forward-Looking Statement
All statements in this press release, other thanstatements of historical fact, are “forward-looking information” with respect to the Company within the meaning of applicable securities laws, including with respect to transaction and future operations of
Copyright (c) 2021 TheNewswire - All rights reserved.
Copyright (c) 2021 TheNewswire - All rights reserved., source